Correlation Between Immix Biopharma and Neximmune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Neximmune, you can compare the effects of market volatilities on Immix Biopharma and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Neximmune.

Diversification Opportunities for Immix Biopharma and Neximmune

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Immix and Neximmune is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Neximmune go up and down completely randomly.

Pair Corralation between Immix Biopharma and Neximmune

Given the investment horizon of 90 days Immix Biopharma is expected to generate 4.74 times less return on investment than Neximmune. But when comparing it to its historical volatility, Immix Biopharma is 2.34 times less risky than Neximmune. It trades about 0.01 of its potential returns per unit of risk. Neximmune is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,050  in Neximmune on August 27, 2024 and sell it today you would lose (807.00) from holding Neximmune or give up 76.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy79.78%
ValuesDaily Returns

Immix Biopharma  vs.  Neximmune

 Performance 
       Timeline  
Immix Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immix Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Neximmune 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Immix Biopharma and Neximmune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immix Biopharma and Neximmune

The main advantage of trading using opposite Immix Biopharma and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.
The idea behind Immix Biopharma and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes